Trade Histogen Inc. - HSTO CFD
Add to favourite- Summary
- Historical Data
- Events
- Ownership
| Spread | 0.0582 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.024068% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | 0.001846% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 20% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
*Information provided by Capital.com
| Prev. Close* | 1.3957 |
| Open* | 1.3059 |
| 1-Year Change* | 321.26% |
| Day's Range* | 1.3059 - 1.4156 |
| 52 wk Range | 0.15-1.23 |
| Average Volume (10 days) | N/A |
| Average Volume (3 months) | 64.45M |
| Market Cap | 7.98M |
| P/E Ratio | -100.00K |
| Shares Outstanding | 49.95M |
| Revenue | 1.03M |
| EPS | -0.40 |
| Dividend (Yield %) | N/A |
| Beta | 0.96 |
| Next Earnings Date | Aug 9, 2022 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Mar 20, 2023 | 1.3957 | 0.0997 | 7.69% | 1.2960 | 1.4256 | 1.1464 |
| Mar 17, 2023 | 1.3359 | 0.2293 | 20.72% | 1.1066 | 1.5951 | 1.0467 |
| Mar 16, 2023 | 0.8203 | -0.0754 | -8.42% | 0.8957 | 0.8957 | 0.8025 |
| Mar 15, 2023 | 0.8797 | -0.0046 | -0.52% | 0.8843 | 0.8997 | 0.8672 |
| Mar 14, 2023 | 0.8997 | 0.0103 | 1.16% | 0.8894 | 0.9030 | 0.8673 |
| Mar 13, 2023 | 0.8992 | -0.0483 | -5.10% | 0.9475 | 0.9625 | 0.8991 |
| Mar 10, 2023 | 0.9371 | 0.0200 | 2.18% | 0.9171 | 0.9371 | 0.9071 |
| Mar 9, 2023 | 0.9291 | -0.0777 | -7.72% | 1.0068 | 1.0168 | 0.8972 |
| Mar 8, 2023 | 1.0268 | -0.0399 | -3.74% | 1.0667 | 1.2262 | 1.0068 |
| Mar 7, 2023 | 1.0268 | 0.1396 | 15.73% | 0.8872 | 1.0468 | 0.8872 |
| Mar 6, 2023 | 0.9073 | -0.0098 | -1.07% | 0.9171 | 0.9171 | 0.9006 |
| Mar 3, 2023 | 0.9072 | -0.0399 | -4.21% | 0.9471 | 0.9471 | 0.9071 |
| Mar 2, 2023 | 0.8972 | 0.0020 | 0.22% | 0.8952 | 0.9072 | 0.8872 |
| Mar 1, 2023 | 0.9371 | -0.0498 | -5.05% | 0.9869 | 0.9869 | 0.9274 |
| Feb 28, 2023 | 0.9969 | 0.0234 | 2.40% | 0.9735 | 1.0068 | 0.9670 |
| Feb 27, 2023 | 0.9869 | -0.0299 | -2.94% | 1.0168 | 1.0368 | 0.9869 |
| Feb 24, 2023 | 0.9969 | -0.0099 | -0.98% | 1.0068 | 1.0168 | 0.9968 |
| Feb 23, 2023 | 1.0168 | 0.0100 | 0.99% | 1.0068 | 1.0368 | 1.0068 |
| Feb 22, 2023 | 1.0268 | 0.0200 | 1.99% | 1.0068 | 1.0368 | 1.0068 |
| Feb 21, 2023 | 1.0068 | -0.0399 | -3.81% | 1.0467 | 1.0467 | 0.9968 |
Histogen Inc. Events
| Time (UTC) | Country | Event |
|---|---|---|
| No events scheduled | ||
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Histogen Inc. Company profile
Histogen Inc., a clinical-stage therapeutics company, focuses on developing therapeutics based upon the products of fibroblast cells grown under simulated embryonic conditions. It offers HST-001, a hair stimulating complex that is in Phase 1b/2a clinical trial for the treatment of androgenic alopecia (hair loss); HST-003, a human extracellular matrix, which is in Phase 1/2 clinical trial to treat articular cartilage defects in the knee; and Emricasan, an orally active pan-caspase inhibitor that is in Phase 1 clinical trial for the treatment of COVID-19. The company''s pre-clinical programs include HST-004, a cell conditioned media (CCM) solution to treat spinal disc repair; and HST-002, a human-derived collagen and extracellular matrix dermal filler for the treatment of facial folds and wrinkles. Histogen Inc. was founded in 2007 and is headquartered in San Diego, California.| Industry: | Bio Therapeutic Drugs |
10655 Sorrento Valley Road
Suite 200
92121
News
Cryptogpt price prediction: What is cryptogpt (GPT)?
Can GPT cash in on the AI bubble?
16:43, 20 March 2023
Polygon price prediction: What is polygon (MATIC)?
Can MATIC outperform the market?
15:44, 20 March 2023
Ethereum price prediction 2030-2050: Will it fit your retirement plan?
What is the outlook for ETH as a long-term investment?
15:27, 20 March 2023
Ripple/SEC Lawsuit: News And Update
Ripple and the US Securities and Exchange Commission are still awaiting a ruling
15:14, 20 March 2023
UBS Group shareholders: Who owns the company that is acquiring troubled bank Credit Suisse?
Now that UBS is acquiring troubled bank Credit Suisse, who are the UBS Group shareholders?
14:20, 20 March 2023
DXY forecast: Will rate hikes support USD dominance?
Interest rate hikes helped the DXY surge to a 20-year high in 2022, but the index has since slid as the Fed has signalled a slowing of its monetary contraction policy. Where next for the DXY?
18:49, 17 March 2023
Woo network price prediction: What is woo network (WOO)?
Can WOO seduce potential investors?
15:05, 17 March 2023People also watch
Still looking for a broker you can trust?
Join the 500.000+ traders worldwide that chose to trade with Capital.com